AAD 2023: Risankizumab Reduces Nail Psoriasis Symptoms in Patients With Psoriatic Arthritis
At 24 weeks, patients achieved improvement in the KEEPsAKE-1 trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.